Aranscia Announces Molecular Laboratory Integration Initiative with Northside Hospital to Advance Precision Oncology
Initiative integrates Aranscia's 2bPrecise and Spesana platforms with leading molecular laboratories to streamline genomic testing across Northside's cancer care network HOUSTON and ATLANTA, Sept. 22, 2026 /PRNewswire/ -- Aranscia today announced a new initiative with Northside Hospital...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Industrial Coatings Expert Jeff DeFranco Explains Industrial Drain Repair in HelloNation
- CRRC presenta su cartera de energía eólica en WindEnergy Hamburg
- U.S. Tech Hiring Moderates as Employers Prioritize Human Skills
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →